Insiders Trades
Qiagen N.V. Stock: price and insider trades · Netherlands
No insider purchase over the last 90 days. The latest was filed 22 May 2026.
Qiagen N.V.: what insiders have been doing
Qiagen N.V. belongs to the Health Care sector. Filings by its managers are published through AFM. Between 18 October 2025 and 18 October 2026, 14 insiders published 36 filings.
Purchases and sales both appear in the filings: 11 purchases (10 insiders) and 7 sales (7 insiders). The totals do not cover 18 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 10 senior executives.
The last insider purchase was made public on 22 May 2026, 149 days ago.
Compared with its exchange (126 companies, median 7 filings), a count of 36 filings is above the norm. Looking back to 2006, when coverage begins, insiders filed 90 purchases and 96 sales.
In the same sector, recent insider purchases at Anixa Biosciences Inc and Vivos Inc also feature in our signals. Every figure here comes from the filings published by AFM and describes the past, not future prices; it is not investment advice.
Insider Decl.
350
Thresholds
n/a
Buy Volume
€1B
90 ops. · all time
Sell Volume
€187M
96 ops. · all time
Who traded when
BuySaleR. Sackers1 buy5 sales
S. Rusckowski3 buys2 sales
T. Haag2 buys2 sales
E. Pisa2 buys1 sale
E.E. Tallett1 buy2 sales
M. Colpan1 buy2 sales
+4 other insiders
Since the insiders bought
- +20.6%Entry 35.09 · Close at T+90 42.32
- +30.4%Entry 32.70 · Close at T+90 42.65
- -9.0%Entry 40.04 · Close at T+90 36.45
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
Last declaration on 4 September 2026
Declarations350 total
172,851 sharesPerformance stock unitsOTCAFM:MAR19:20260901D4CE9A5C-E6AF-4F4C-809A-ACD856CA63C4
29,150 sharesGewoon aandeelAFM:193942
Canonical exit: 17 Aug 2026 (T+90)
60,000 sharesGewoon aandeelAFM:193511
Canonical exit: 10 Aug 2026 (T+90)
-4,705 sharesRestricted share awardAFM:188999
-900 sharesRestricted share awardAFM:188993
-119,695 sharesRestricted share awardAFM:188984
-5,990 sharesRestricted share awardAFM:189031
-67,723 sharesRestricted share awardAFM:188955
-5,990 sharesRestricted share awardAFM:189028
-9,156 sharesRestricted share awardAFM:189030
-5,990 sharesRestricted share awardAFM:189026
4,618 sharesRestricted share awardAFM:189011
Canonical exit: 28 May 2026 (T+90)
4,618 sharesRestricted share awardAFM:189014
Canonical exit: 28 May 2026 (T+90)
4,618 sharesRestricted share awardAFM:189015
Canonical exit: 28 May 2026 (T+90)
4,618 sharesRestricted share awardAFM:189013
Canonical exit: 28 May 2026 (T+90)
70,305 sharesRestricted share awardAFM:189016
Canonical exit: 28 May 2026 (T+90)
4,618 sharesRestricted share awardAFM:189005
Canonical exit: 28 May 2026 (T+90)
25 of 350 declarations
About Qiagen N.V.
Qiagen N.V. is a company specializing in molecular biology technologies, providing solutions for diagnostics and research. It is listed on the Amsterdam Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
